You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

CME Learning Center


Latest Clinical Briefs

About Myeloid/Leukemia

The myeloid disorders—including acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and the preleukemic disorders myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPNs)—are characterized by a disruption in the normal growth and development of nonlymphocytic blood cells. Along with acute lymphocytic leukemia (ALL), these diseases are collectively diagnosed in over 40,000 people each year in the United States. Research advances in these disorders over the past decade have led to the development of better diagnostic, classification, and risk stratification schemas; new pharmacologic agents and treatment protocols; and, ultimately, improved patient outcomes.